SOPHiA GENETICS: Camblong plans $530K share sale
The notice identifies vested restricted stock units and founder shares as the sources of the proposed shares.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
SOPHiA GENETICS SA common shares are the subject of Jurgi Camblong’s Rule 144 notice, which lists a proposed sale of 65,672 shares with an aggregate market value of $529,973.04 and an anticipated sale date of October 5, 2026. The shares include 40,172 shares tied to restricted stock units that vested on October 2 and October 3, 2026, and 25,500 founder shares listed with an acquisition date of March 18, 2021. The sale information names Morgan Stanley Smith Barney LLC and Nasdaq, and lists 85,127,825 shares outstanding. The preceding-three-months table also lists earlier transactions as 10b5-1 sales.
Key Figures
Key Terms
Rule 144 regulatory
Restricted Stock Units financial
10b5-1 Sales financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What earlier SOPH sales did Jurgi Camblong report?
AI-generated analysis. How Rhea-AI works. Not financial advice.